Invest in

Biotech Breakthroughs

1.2%
1.5%
2.2%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
1.2%
1.5%
2.2%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
Open a Motif account to view and trade this basket of stocks:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
49.5% Research & Diagnostics 10.3%
13.2% Danaher Corporation DHR 8.8%
12.2% Thermo Fisher Scientific Inc. TMO 24.7%
6.2% 8xxxxxxxxx 8xxxxxxxxxx 8x 8xxxxxx 8xxxxx 8x 88.8%
4.9% 8xxxxx 8xxxxxxxxxx 8xx 88.8%
4.2% 8xxxxxx 8xxxxxxxxxxx 8xx 8 88.8%
3.8% 8xxxxxxxxxx 8xxx 8xx 88.8%
2.0% 8xxxxxx 8xxxx 8xxxxxxxxxxx 8xxxxxxxxxxxx 8xx 88.8%
1.9% 8xxxxxxxxx 8xxx 8xxx 88.8%
1.1% 8xxxxxxxxxxxxx 8xxxxxxxxxxxx 8xxx 8xx 88.8%
35.6% Mature Biotechnology 1.2%
15.9% Amgen Inc. AMGN 13.0%
8.8% 8xxxxx 8xxxxxxx 8xxx 8xxx 88.8%
6.1% 8xxxxx 8xxx 8xxx 88.8%
4.8% 8xxxxxx 8xxxxxxxxxx 8xxx 88.8%
8.2% Commercial Growth Biotech 0.5%
4.2% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
4.0% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
4.0% Early Commercial Biotech 6.1%
4.0% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.5% Other Biotech 63.6%
0.8% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
0.7% 8xxxxx 8xxxxxxxxxxx 8x 8xxx 88.8%
1.2% Development Stage Biotech 30.5%
0.6% 8x 8xxxxxxxxxxx 8xxx 8xxx 88.8%
0.6% 8xxxxx 8xxxxxxxxxxxxxx 8xxxxxxxxxxx 8xxx 88.8%

Quotes delayed 15 mins. Currently Dec 16, 2018 11:24:57 AM. Fields are marked with -- when data is unavailable.